Skip to content

Cost-effectiveness analysis of baseline testing for resistance-associated polymorphisms to optimise treatment outcome in genotype 1 non-cirrhotic treatment-naïve patients with chronic hepatitis c virus

Research output: Contribution to journalArticle

Original languageEnglish
JournalValue in Health
DOIs
DateAccepted/In press - 1 Aug 2019
DatePublished (current) - 27 Aug 2019

Documents

Documents

  • Full-text PDF (author’s accepted manuscript)

    Rights statement: This is the author accepted manuscript (AAM). The final published version (version of record) is available online via Elsevier at 10.1016/j.jval.2018.04.043. Please refer to any applicable terms of use of the publisher.

    Accepted author manuscript, 182 KB, Word document

    Embargo ends: 27/08/20

    Request copy

  • Full-text PDF (author’s accepted manuscript)

    Rights statement: This is the author accepted manuscript (AAM). The final published version (version of record) is available online via Elsevier at 10.1016/j.jval.2018.04.043. Please refer to any applicable terms of use of the publisher.

    Accepted author manuscript, 316 KB, PDF document

    Embargo ends: 27/08/20

    Request copy

DOI

View research connections

Related faculties, schools or groups